Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

NCT02947347

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Southern Cancer Center Mobile, Alabama, United States
  • City of Hope Duarte, California, United States
  • Sansum Clinic Santa Barbara, California, United States
  • UCLA Hematology/Oncology Santa Monica, California, United States
View all 128 locations
View Trial Details
Completed

Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy

NCT04703686

Conditions
Diffuse Large B-cell Lymphoma Refractory, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • CHU Amiens Picardie Site sud Amiens, France
  • CHU de Clermont Ferrand Clermont-Ferrand, France
  • Hopital Henri Mondor Créteil, France
  • CHU de Dijon - Hôpital le Bocage Dijon, France
View all 19 locations
View Trial Details
Completed

S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma

NCT00006721

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 259 locations
View Trial Details
Completed

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

NCT02213913

Conditions
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, +104 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
  • NorthShore University HealthSystem Evanston, Illinois, United States
View Trial Details
Completed

A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

NCT02723994

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations
  • The Childrens Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Children'S Hospital Phoenix, Arizona, United States
  • Arkansas Childrens Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Fontana, California, United States
View all 111 locations
View Trial Details
Completed

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

NCT03458260

Conditions
Aggressive Non-Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations
  • AZ Sint Jan Bruges, Belgium
  • Institut Jules Bordet - Centre des tumeurs de l'ULB Brussels, Belgium
  • Centre Hospitalier de Jolimont Haine-Saint-Paul, Belgium
  • CH d'Avignon Avignon, France
View all 22 locations
View Trial Details

Related conditions